JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Compare Urothelial carcinoma medicines

Compare Urothelial carcinoma medicines

Bavencio (avelumab) vs Padcev (enfortumab vedotin-ejfv)

Bavencio (avelumab) vs Trodelvy (sacituzumab govitecan-hziy)

Imfinzi (durvalumab) vs Bavencio (avelumab)

Imfinzi (durvalumab) vs Padcev (enfortumab vedotin-ejfv)

Imfinzi (durvalumab) vs Trodelvy (sacituzumab govitecan-hziy)

Keytruda (pembrolizumab) vs Padcev (enfortumab vedotin-ejfv)

Opdivo (Nivolumab) vs Padcev (enfortumab vedotin-ejfv)

Opdivo (Nivolumab) vs Trodelvy (sacituzumab govitecan-hziy)

Tecentriq (Atezolizumab) vs Bavencio (avelumab)

Tecentriq (Atezolizumab) vs Padcev (enfortumab vedotin-ejfv)

Trodelvy (sacituzumab govitecan-hziy) vs Padcev (enfortumab vedotin-ejfv)

0